Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-04-20 @ 3:15 PM
Study NCT ID:
NCT02406833
Status:
COMPLETED
Last Update Posted:
2018-02-28
First Post:
2015-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy
Sponsor:
Isarna Therapeutics GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-25
First Submit QC Date:
None
Study First Post Date:
2015-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-27
Last Update Post Date:
2018-02-28
Last Update Post Date Type:
ACTUAL